首页> 外文期刊>Frontiers in Pharmacology >Focused Ultrasound Improves NK-92MI Cells Infiltration Into Tumors
【24h】

Focused Ultrasound Improves NK-92MI Cells Infiltration Into Tumors

机译:聚焦超声可改善NK-92MI细胞向肿瘤的浸润

获取原文
           

摘要

The efficiency of natural killer (NK) cells, adoptively transferred, for treatment against solid tumors is hindered by their difficulty to enter tumors from the blood circulation as well as their inability to prolong viability in the absence of IL-2. Among different sources of NK cells, we used genetically modified NK-92MI cells, a suitable candidate which can release IL-2 to maintain their viability and overcome undesirable side effects caused by systemic administration of exogenous IL-2. In this study, we evaluated whether the combination of focused ultrasound (FUS) and microbubbles can improve adoptively NK-92MI cell infiltration into ovarian tumors through biodistribution, immunofluorescence, and flow cytometry. The treatment effects of using this strategy twice a week were explored. The potential molecular mechanism of FUS assisting NK cell therapy was also initially explored through evaluating the expression of ICAM1 and CX3CL1 by qRT-PCR. Our results indicated that FUS and microbubbles can improve NK-92MI cells’ infiltration into tumors, and the combination of FUS and NK-92MI cells had a better treatment effect compared to the PBS group, but not compared to the NK-92MI group. The qRT-PCR results also showed that CX3CL1 may be involved in the process of FUS-assisted NK cell infiltration. These results indicate that further optimization of the FUS-assisted strategy is still needed to achieve therapeutic benefit.
机译:过继转移的天然杀伤(NK)细胞治疗实体瘤的效率受到阻碍,因为它们难以从血液循环进入肿瘤以及在没有IL-2的情况下无法延长生存能力。在不同来源的NK细胞中,我们使用了基因修饰的NK-92MI细胞,这是一种合适的候选物,可以释放IL-2来维持其生存能力,并克服因外源性IL-2的全身性给药而引起的不良副作用。在这项研究中,我们评估了聚焦超声(FUS)和微泡的组合是否可以通过生物分布,免疫荧光和流式细胞术改善过继性NK-92MI细胞向卵巢肿瘤的浸润。探索了每周两次使用该策略的治疗效果。还通过qRT-PCR评估ICAM1和CX3CL1的表达,初步探索了FUS辅助NK细胞治疗的潜在分子机制。我们的结果表明,FUS和微泡可以改善NK-92MI细胞对肿瘤的浸润,与PBS组相比,FUS和NK-92MI细胞的组合具有更好的治疗效果,但与NK-92MI组相比则没有。 qRT-PCR结果还表明,CX3CL1可能参与FUS辅助NK细胞浸润的过程。这些结果表明,仍需要进一步优化FUS辅助策略以实现治疗效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号